Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment
Public ClinicalTrials.gov record NCT00083967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Rhegmatogenous Retinal Detachment
Study identification
- NCT ID
- NCT00083967
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Interventions
- denufosol tetrasodium (INS37217) Intravitreal Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2004
- Primary completion
- Mar 31, 2006
- Completion
- Mar 31, 2006
- Last update posted
- Apr 9, 2015
2004 – 2006
United States locations
- U.S. sites
- 33
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Center, P.C. | Tucson | Arizona | 85704 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Retina Vitreous Associates Medical Group | Los Angeles | California | 90017 | — |
| Retina Consultants San Diego | Poway | California | 92064 | — |
| Danbury Eye Physicians & Surgeons, P.C. | Danbury | Connecticut | 06810 | — |
| Retina Group of Florida | Fort Lauderdale | Florida | 33334 | — |
| Central Florida Retina | Orlando | Florida | 32806 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Illinois Retina Associates, S.C. | Joliet | Illinois | 60435 | — |
| Midwest Eye Institute | Indianapolis | Indiana | 46280 | — |
| University of Kentucky, The Kentucky Clinic | Lexington | Kentucky | 40536 | — |
| Maine Vitreoretinal Consultants | Bangor | Maine | 04401 | — |
| National Retina Institute | Chevy Chase | Maryland | 20815 | — |
| New England Eye Center | Boston | Massachusetts | 02111 | — |
| Kresge Eye Institute/Hutzel Hospital | Detroit | Michigan | 48201 | — |
| Retina Associates | Kansas City | Missouri | 64111 | — |
| Retina Associates of NJ | Millburn | New Jersey | 07041 | — |
| Retina Associates of NJ | Teaneck | New Jersey | 07666 | — |
| Retina Associates of NJ | Wayne | New Jersey | 07470 | — |
| NY Eye and Ear Infirmary | New York | New York | 10003 | — |
| Carolina Eye Associates | Southern Pines | North Carolina | 28387 | — |
| Retina Associates of Cleveland | Beachwood | Ohio | 44122 | — |
| Retina Assocites of Cleveland, Inc. | Cleveland | Ohio | 44107 | — |
| Cleveland Clinical Foundation | Cleveland | Ohio | 44195 | — |
| Retina Associates of Cleveland | Lakewood | Ohio | 44107 | — |
| Retina Associates of Cleveland | Lorain | Ohio | 44052 | — |
| Retina Associates of Cleveland | Middleburg Heights | Ohio | 44130 | — |
| Scheie Eye Institute | Philadelphia | Pennsylvania | 19104 | — |
| Austin Retina | Austin | Texas | 78705 | — |
| Vitreoretinal Consultants | Houston | Texas | 77030 | — |
| Wagner Mandell Retina Center | Norfolk | Virginia | 23505 | — |
| Wagner Mandell Retina Center | Virginia Beach | Virginia | 23454 | — |
| Medical College of Wisconsin/The Eye Institute | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00083967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2015 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00083967 live on ClinicalTrials.gov.